Phase II, proof-of-concept randomized controlled trial to evaluate dental caries preventive effects of fluoridated bottle water
Phase II, proof-of-concept randomized controlled trial to evaluate dental caries preventive effects of fluoridated bottle water
批准号:
10458235
负责人:
Gary Douglas Slade
金额:
$104.92万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-09-17 至 2026-09-16
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Dental health benefits of fluoride in drinking water have never been tested in a randomized controlled trial
(RCT). Instead, results from observational studies and a few non-randomized, community intervention studies
were sufficient to justify addition of fluoride to many public water systems during the 20th century and to defend
against fluoridation’s critics. However, growth in fluoridated public water systems has stalled, leaving 100
million Americans living in places that do not have fluoridated water and which probably never will. A related
problem is that, nationwide, 15% of children do not drink tap water for reasons ranging from consumer
preference to distrust of public water. One solution, capitalizing on consumers’ demand for bottled water, is to
increase consumption of fluoridated bottled water. However, RCT evidence of dental health benefits of
fluoridated bottled water will be essential if public health is to embrace it as a strategy to extend fluoridation. In
the absence of a precedent, and in the face of uncertainty as to compliance and likely effect size of the
intervention, a fully powered RCT is premature. We instead propose a phase II, proof-of-concept RCT to
evaluate dental caries preventive effects of fluoridated bottled water in a community not served by water
fluoridation. The primary recruitment population is ~470 babies born during a one-year period in Kinston, NC,
the state’s community with the largest non-fluoridated public water system where caries prevalence exceeds
the state average. In households where measured content of fluoride in tap water is <0.2 ppm, we will
randomize 200 infant/family dyads in a 1:1 ratio to receive either fluoridated or non-fluoridated bottled water.
The two types of commercially water in 5-gallon bottles will be relabeled to mask infants, families and
researchers as to the fluoride content. For 3½ years after randomization, each household will be provided with
water, dispensers and other supplies to encourage water consumption consistent with nutritional
recommendations. Bottled water consumption will be monitored and fingernail clippings collected to provide a
biomarker-measure of fluoride intake. A dental examination conducted when children are aged 48?3 months
will measure caries experience using the index of decayed, missing and filled tooth surfaces (dmfs). Statistical
analysis will compare mean dmfs between study-groups to generate effect size estimates and standard errors
needed to calculate sample size requirement for a future, multi-site, Phase III RCT. The investigative team has
a strong record of accomplishment in observational and interventional studies of dental caries in children, and
is experienced in work needed to plan (during the UG3 phase) and conduct (during the 5-year UH3 phase) the
study as required by PAR-18-547. Local, state and national stakeholders have expressed support for the
proposed study, noting its potential to improve oral health in underserved communities. By applying the rigor of
a placebo-controlled RCT design, the study will address a serious shortfall in the evidence that hampers the
nation’s primary public health strategy for dental caries prevention.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Phase II, proof-of-concept randomized controlled trial to evaluate dental caries preventive effects of fluoridated bottle water
-
批准号:10472070
-
项目类别:
-
资助金额:$106.48万
-
财政年份:2021
-
负责人:Gary Douglas Slade
-
依托单位:
Is Periodontal Disease Involved in the Etiology of Non-Alcoholic Fatty Liver Disease
-
批准号:9111407
-
项目类别:
-
资助金额:$15.2万
-
财政年份:2016
-
负责人:Gary Douglas Slade
-
依托单位:
Is Periodontal Disease Involved in the Etiology of Non-Alcoholic Fatty Liver Disease
-
批准号:9233074
-
项目类别:
-
资助金额:$15.2万
-
财政年份:2016
-
负责人:Gary Douglas Slade
-
依托单位:
Effects of cumulative stress and change in pain regulation on risk of chronic TMD
-
批准号:8440291
-
项目类别:
-
资助金额:$14.0万
-
财政年份:2012
-
负责人:Gary Douglas Slade
-
依托单位:
Effects of cumulative stress and change in pain regulation on risk of chronic TMD
-
批准号:8282086
-
项目类别:
-
资助金额:$14.59万
-
财政年份:2012
-
负责人:Gary Douglas Slade
-
依托单位:
Planning for International Studies of Population Oral Health Determinants
-
批准号:7449834
-
项目类别:
-
资助金额:$10.63万
-
财政年份:2008
-
负责人:Gary Douglas Slade
-
依托单位:
Planning for International Studies of Population Oral Health Determinants
-
批准号:7643354
-
项目类别:
-
资助金额:$13.13万
-
财政年份:2008
-
负责人:Gary Douglas Slade
-
依托单位:
Etiology and Modeling Core
-
批准号:8457069
-
项目类别:
-
资助金额:$33.57万
-
财政年份:2004
-
负责人:Gary Douglas Slade
-
依托单位:
Etiology and Modeling Core
-
批准号:8274677
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2004
-
负责人:Gary Douglas Slade
-
依托单位:
Etiology and Modeling Core
-
批准号:8425167
-
项目类别:
-
资助金额:$20.16万
-
财政年份:2004
-
负责人:Gary Douglas Slade
-
依托单位:
Etiology and Modeling Core
-
批准号:8457068
-
项目类别:
-
资助金额:$3.5万
-
财政年份:2004
-
负责人:Gary Douglas Slade
-
依托单位:
Etiology and Modeling Core
-
批准号:7931740
-
项目类别:
-
资助金额:$20.03万
-
财政年份:2004
-
负责人:Gary Douglas Slade
-
依托单位:
Etiology and Modeling Core
-
批准号:8650339
-
项目类别:
-
资助金额:$21.57万
-
财政年份:2004
-
负责人:Gary Douglas Slade
-
依托单位:
ACUTE PHASE REACTANTS IN PERIODONTITIS AND CARDIOVASCULAR DISEASE
-
批准号:6156424
-
项目类别:
-
资助金额:$6.61万
-
财政年份:1999
-
负责人:Gary Douglas Slade
-
依托单位:
EFFECTS OF ORAL AND SYSTEMIC DISEASE ON QUALITY OF LIFE
-
批准号:6156525
-
项目类别:
-
资助金额:$0.01万
-
财政年份:1999
-
负责人:Gary Douglas Slade
-
依托单位:
QUALITY OF LIFE OUTCOMES FOR ORAL HEALTH CARE
-
批准号:2713294
-
项目类别:
-
资助金额:$9.5万
-
财政年份:1997
-
负责人:Gary Douglas Slade
-
依托单位:
QUALITY OF LIFE OUTCOMES FOR ORAL HEALTH CARE
-
批准号:6379820
-
项目类别:
-
资助金额:$7.56万
-
财政年份:1997
-
负责人:Gary Douglas Slade
-
依托单位:
QUALITY OF LIFE OUTCOMES FOR ORAL HEALTH CARE
-
批准号:2897172
-
项目类别:
-
资助金额:$11.19万
-
财政年份:1997
-
负责人:Gary Douglas Slade
-
依托单位:
QUALITY OF LIFE OUTCOMES FOR ORAL HEALTH CARE
-
批准号:6176978
-
项目类别:
-
资助金额:$11.37万
-
财政年份:1997
-
负责人:Gary Douglas Slade
-
依托单位:
QUALITY OF LIFE OUTCOMES FOR ORAL HEALTH CARE
-
批准号:2395872
-
项目类别:
-
资助金额:$10.19万
-
财政年份:1997
-
负责人:Gary Douglas Slade
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于生境成像与深度学习联合临床特征构建II型卵巢癌术前淋巴结转移预测模型的研究
-
批准号:2026JJ81984
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨石平
-
依托单位:
鸡软骨非变性II型胶原高效制备和靶向递送的关键技术开发与应用示范
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:赵子方
-
依托单位:
青蒿琥酯协同TROP2/线粒体级联靶向的NIR-II多模态诊疗用于晚期TNBC精准诊断与治疗的机制研究
-
批准号:2026JJ30126
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨沙
-
依托单位:
苏合颗粒治疗慢性萎缩性胃炎的临床(II期)评价关键技术研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:蒋晓波
-
依托单位:
医工融合策略下的新型NIR-II有机探针用于中晚期肝癌精准诊断与协同治疗
-
批准号:2026JJ30093
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈国栋
-
依托单位:
用于肺纤维化实时动态监测的NIR-II稀土纳米探针研究
-
批准号:JCZRLH202600246
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
以数据与知识双驱动的NIR-II荧光成像智能分析新范式与基础算法
-
批准号:JCZRMS202600521
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
桥粒斑蛋白调控II型肺泡上皮细胞凋亡易感性而促进特发性肺纤维化形成的机制研究
-
批准号:2026JJ70015
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:彭菲
-
依托单位:
光敏型钌(II)配合物与喜树碱协同给药抗肝癌活性及作用机制研究
-
批准号:2026JJ81924
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:谷依盈
-
依托单位:
草鱼免疫球蛋白与GCRV-II互作机制及高效疫苗创制
-
批准号:JCZRQNA202600094
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位: